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Abstract
Background: Colorectal cancer (CRC) is a common and lethal disease with thousands of new
cases of large bowel cancer diagnosed in the United States each year. Colorectal cancer frequently
causes obstruction of the large bowel. Cases of obstructions and perforations have been
documented with masses well below 6 cm in diameter. Obstruction and/or perforation are
important predictors of prognosis with respect to colorectal carcinomas.
Case Presentation: The following is the presentation of an unusual case of a 13 × 12 × 16 cm
colonic adenocarcinoma without any signs of obstruction or perforation.
Conclusion: Perioperative mortality rates for colorectal cancer with obstruction have been
documented anywhere from 5% to 47.6%, making obstruction an important predictive factor in
long-term patient survival. Although a correlation between obstruction and patient outcome has
been determined, a correlation between colorectal tumor size/staging and obstruction has yet to
be investigated.
Introduction
Colorectal cancer (CRC) is a common and lethal disease
with over 150,000 new cases of large bowel cancer diag-
nosed each year in the United States[1]. In the U.S.,
obstruction of the large bowel is most frequently caused
by colorectal cancer[2]. Bowel obstruction occurs when
the normal flow of bowel contents is interrupted. Small
bowel obstruction in patients with cancer is a common
and difficult problem and has been described in up to 28
percent of patients with colorectal carcinoma[3]. In a
study by Maurer, CA et al, of 69 patients with large bowel
obstruction, 38 percent were associated with colorectal
carcinoma[4]. Cases of obstructions and perforations
have been documented with masses well below 6 cm in
diameter. The following is the presentation of an unusual
case of a 13 × 12 × 16 cm colonic adenocarcinoma with-
out any signs of obstruction or perforation.
Case Presentation
A 58 year old Caucasian male with a history of iron defi-
ciency anemia and severe depression presented with
weakness and shortness of breath, along with a loss of
appetite and thirty pound weight loss. He also has a long
history of psychological issues, including extensive illicit
drug use, bipolar personality disorder, anxiety, chronic
depression, and suicidal tendencies. He denied any con-
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nausea, vomiting, or abdominal pain. He did, however,
report feeling a firm mass in his right upper and lower
abdominal quadrants, which he claims has grown in size
over the years.
Upon physical examination, the patient was found to
appear thin, pale, but comfortable. He was found to have
normal bowel sounds in all four quadrants; however,
there was a large firm, non-tender mass palpated in the
right upper and lower quadrants. Also, bilateral mildly
reducible inguinal hernias and a large umbilical hernia
were detected. Patient's exam was otherwise normal.
The patient presented with a hemoglobin/hematocrit
ratio of 7/25.7 and an albumin level of 2.9. He was there-
fore admitted for blood transfusions and further workup
of a mass detected in his upper and lower right abdominal
quadrants. Computed Tomography (CT) with contrast
was performed which showed a large 13 × 12 × 16 cm
right-sided ill-defined soft tissue mass involving the
ascending colon (Fig 1 and 2). CT-guided fine needle aspi-
ration and core biopsy were also performed which
revealed adenocarcinoma. Carcinoembryonic antigen
(CEA) was 69.7.
After a week of total parenteral nutrition, the patient was
taken to the operating room to undergo tumor resection
under general anesthesia. Adequate exposure was attained
by a vertical incision across the midline of the abdomen
with a transverse extension to the right. Surgical planes
were created to resect the colonic mass en bloc with the
invaded appendix, ascending/transverse colon, loop of
ileum, and right abdominal wall/retroperitoneum. Liver,
ileocolic mesentery, and para-aortic regions were without
adenopathy or mass. Proximal and distal surgical margins
were clear and no residual tumor was left behind. Pathol-
ogy reported the greater than 6 lb mass (Fig 3) to have 0/
16 nodes positive for metastatic adenocarcinoma.
The patient has recovered well without complications,
except for mild ileus, and was discharged on postoperative
day fourteen to follow up for possible adjuvant chemo-
therapy.
Discussion
Although the patient underwent surgery without compli-
cations, there is no doubt that his mental illness prevented
him from seeking medical care sooner. It is unusual that
the abdominal mass grew as large as it did without signs
of bowel obstruction or perforation.
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cer is a common and difficult problem and has been
described in 28–38 percent of patients with colorectal car-
cinoma[3,4]. Cases of obstructions and perforations have
been documented with masses well below 6 cm in diam-
eter. This is an unusual case of a 13 × 12 × 16 cm colonic
adenocarcinoma without any signs of obstruction or per-
foration.
Obstruction and/or perforation are important predictors
of prognosis with respect to colorectal carcinomas. In ade-
nocarcinoma of the colon, obstruction and perforation
have been documented to have occurred at the site of the
neoplasm and/or proximal. In one study alone, close to
2000 cases of colorectal adenocarcinoma with obstruc-
tion and perforation were examined and showed that
both events carry a poor prognosis[5]. In a study by Wang
et al, of 256 patient outcomes examined, survival rates
were significantly lower in obstructed patients. This study
also found obstruction status as an independent prognos-
tic factor for patients with right colon carcinoma[6].
Studies across the world consistently show poorer out-
comes for patients with obstructive colorectal cancer as
opposed to non-obstructed cancer. A study performed in
Asia documented the perioperative mortality rate for
colorectal cancer with obstruction to be 5% and the 5-year
survival to be 33%[5]. Zucchetti et al showed that radi-
cally resected obstructed patients had a disease-related
death rate of 47.6% versus 16.3% for non-obstructed
ones. Their study, performed in Europe, concluded that
obstruction itself represented an independent unfavora-
ble factor negatively affecting long term prognosis, even
after radical resection.[7] In another study done in South
America, Torres-Zavala et al showed survival rate of
patients with obstructive colorectal cancer to be 9.5% ver-
sus 35.1% for non-obstructive ones[8].
The cancerous mass removed from the patient in this case
was Stage IIB (T4, N0, M0), according to the American
Joint Committee on Cancer staging system for colorectal
cancer (Table 1)[9].
In this case, the tumor had invaded the retroperitoneal tis-
sue (T4), zero out of sixteen nodes were found positive
(N0), and no distant metastasis was discovered (M0). It is
highly unusual that this Stage IIB (T4, N0, M0) tumor was
found without any signs of obstruction or perforation.
Nevertheless, one cannot dismiss the fact that the patient's
mental status could have "blunted" his true physical pres-
entation. In other words, with chronically depressed indi-
viduals, such as in this case, it is difficult to determine
whether the loss of appetite and weight loss is secondary
to their mental illness(es) or cancer. Even with a thorough
history and physical, the clinician can be misguided, espe-
cially if the patient is not presenting other symptoms that
would make him/her more suspicious of other underlying
conditions.
Conclusion
The incidence of colorectal cancer makes it a very com-
mon disease process across the world. Perioperative mor-
tality rates for colorectal cancer with obstruction have
been documented anywhere from 5% to 47.6%, making
obstruction an important predictive factor in long-term
patient survival. Although a correlation between obstruc-
tion and patient outcome has been determined, a correla-
tion between colorectal tumor size/staging and
obstruction has yet to be investigated.
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Table 1: TNM Staging System for Colorectal Cancer
Primary Tumor (T)
Tis: Carcinoma in situ; intraepithelial (within glandular basement membrane) or invasion of lamina propria (intramucosal)
T1: Tumor invades submucosa
T2: Tumor invades muscularis propria
T3: Tumor invades through the muscularis propria into the subserosa, or into nonperiotonealized pericolic or perirectal tissues
T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum
Regional Lymph Node (N)
NX: Regional nodes cannot be assessed
N0: No regional node metastases
N1: Metastasis in 1 to 3 regional lymph nodes
N2: Metastasis in 4 or more regional lymph nodes
Distant Metastasis (M)
MX: Distant metastasis cannot be assessed
M0: No distant metastasis
M1: Distant metastasis
Stage Groupings
Stage 0: Tis, N0, M0
Stage I: T1-2, N0, M0
Stage IIA: T3, N0, M0
Stage IIB: T4, N0, M0
Stage IIIA: T1-2, N1, M0
Stage IIIB: T3-4, N1, M0
Stage IIIC: Any T, N2, M0
Stage IV: Any T, Any N, M1
The original source for this material is the AJCC Cancer Staging Manual, Sixth Edition (2002) published by Springer-Verlag New York, Inc[6].
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